Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Ampio Pharmaceuticals, Inc.

AMEX: AMPEHealthcare / Biotechnology / USA
0.6400-0.0300-4.48%Vol 625 1971Y Perf -76.54%
Feb 21st, 2019 16:00
BID0.6400 ASK0.6500
Open0.6900 Previous Close0.6700
Pre-Market- After-Trading0.64
 - -%  - -%
Target Price
- 
Analyst Rating
— 0.00
Potencial %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)68 
Earnings Rating
Buy
Price Range Ratio 52wk %
8.19 
Earnings Date
5th Mar 2019

Today's Price Range

0.63000.6900

 

52wk Range

0.35003.89

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
28.00%
3 Months
10.34%
6 Months
1.59%
1 Year
-76.54%
3 Years
-72.29%
5 Years
-92.87%

Quotes

Name / TickerPriceChg.Chg.%
AMPE0.6400-0.0300-4.48
AAPL171.06-0.9700-0.56
GOOG1 096.97-16.8300-1.51
MSFT109.412.26002.11
XOM77.82-0.7100-0.90
WFC49.56-0.2500-0.50
JNJ135.42-0.9300-0.68
FB160.04-2.5200-1.55
GE10.03-0.0700-0.69
JPM105.47-0.2200-0.21
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
5.00
Current Ratio
5.30
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-
Leverage Ratio -4.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
28.66
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-6.20
Cash Flow Per Share
-0.15
Price to Tangible Book
28.66
Book Value per Share
0.02
Enterprise Value (in ths.)
55 433
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-122.84
ROE last 12 Months
-1 045.91
Return on Assets (5Y Avg)
-261.55
ROA last 12 Months
-85.79
Return on Capital (5Y Avg)
-
ROC last 12 Months
-1 046.95
Return on invested Capital Q
-
Return on invested Capital Y
-
Assets Turnover
0.00
Receivables Turnover
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q02 2016--0.10-
Q01 2016--0.13-
Q04 2015--0.19-
Q03 2015--0.14-
Q02 2015--0.14-
Q01 2015--0.14-
Q03 2014-0.17-0.18-5.88
Q02 2014-0.24-0.1729.17
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date5th Mar 2019
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume625 197
Shares Outstanding (in ths.)106 717
Trades Count1 125
Dollar Volume392 135
Avg. Volume680 068
Avg. Weekly Volume664 874
Avg. Monthly Volume732 854
Avg. Quarterly Volume1 124 620

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

33%67%

Bearish Bullish

63%38%

Bearish Bullish

88%12%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Strong Buy
1.00

There are no comments yet.

News